Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 1.13 0 (0%) Market Cap: 288.79 Mil Enterprise Value: 169.64 Mil PE Ratio: 0 PB Ratio: 6.71 GF Score: 64/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1